Literature DB >> 32349859

Effects of Colonization of Gnotobiotic Swiss Webster Mice with Helicobacter bilis.

Mark T Whary1, Chuanwu Wang2, Catherine F Ruff2, Mallory J DiVincenzo2, Caralyn Labriola2, Lillian Ge2, Yan Feng2, Zhongming Ge2, Vasu Bakthavatchalu2, Suresh Muthupalani2, Bruce H Horwitz3, James G Fox4.   

Abstract

Helicobacter bilis (Hb) causes hepatitis in some strains of inbred mice. The current study confirmed that Hb directly causes portal hepatitis in outbred gnotobiotic Swiss Webster (SW) mice, as we previously reported for conventional SW mice. Hbmonoassociated SW mice also developed mild enterocolitis, expanded gut-associated lymphoid tissue (GALT), and tertiary lymphoid tissue in the lower bowel. At 1 and 10 mo after infection, Hb-induced GALT hyperplasia exhibited well-organized, ectopic germinal centers with increased mononuclear cell apoptosis, MHC class II antigen presentation, and pronounced endothelial venule formation, consistent with features of tertiary lymphoid tissue. In the lower bowel, Hb induced mainly B220+ cells as well as CD4+ IL17+, CD4+ IFNγ+, and CD4+ FoxP3+ regulatory T cells and significantly increased IL10 mRNA expression. This gnotobiotic model confirmed that Hb causes portal hepatitis in outbred SW mice but stimulated GALT with an antiinflammatory bias. Because Hb had both anti- and proinflammatory effects on GALT, it should be considered a 'pathosymbiont provocateur' and merits further evaluation in mouse models of human disease.

Entities:  

Year:  2020        PMID: 32349859      PMCID: PMC7287385          DOI: 10.30802/AALAS-CM-19-000087

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  45 in total

Review 1.  Histopathologic approaches to detect changes indicative of immunotoxicity.

Authors:  C F Kuper; J H Harleman; H B Richter-Reichelm; J G Vos
Journal:  Toxicol Pathol       Date:  2000 May-Jun       Impact factor: 1.902

Review 2.  Normal structure, function, and histology of mucosa-associated lymphoid tissue.

Authors:  Mark F Cesta
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

3.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

4.  Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis.

Authors:  J G Fox; F E Dewhirst; Z Shen; Y Feng; N S Taylor; B J Paster; R L Ericson; C N Lau; P Correa; J C Araya; I Roa
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

5.  Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Authors:  Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Sabine Escobar; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 6.  Natural and experimental Helicobacter infections.

Authors:  Mark T Whary; James G Fox
Journal:  Comp Med       Date:  2004-04       Impact factor: 0.982

7.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

8.  Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice.

Authors:  J W Carter; H K Lancaster; W E Hardman; I L Cameron
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

9.  Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma.

Authors:  Paola Pisani; Mark T Whary; Ingrid Nilsson; Supannee Sriamporn; Torkel Wadström; James G Fox; Asa Ljungh; David Forman
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

10.  Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing.

Authors:  Shunsuke Takahashi; Junko Tomita; Kaori Nishioka; Takayoshi Hisada; Miyuki Nishijima
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.